Skip to main content

Beneficial ownership — 13D / 13G

87,314 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
TANG CAPITAL MANAGEMENT, LLC ACRS Aclaris Therapeutics, Inc. 13G/A 2.5% 2y
BIOTECHNOLOGY VALUE FUND L P ELEV Elevation Oncology, Inc. Common stock 13G/A 9.99% 2y
Sotirios J. Vahaviolos MG Mistras Group, Inc. 13G/A 6% 2y
Westchester Capital Management, LLC VMCAF Valuence Merger Corp. I 13G 9.94% 2y
Venrock Healthcare Capital Partners II, L.P. LYRA Lyra Therapeutics, Inc. 13G/A 10% 2y
G1 Execution Services, LLC MSTR Strategy Inc 13G/A 6.1% 2y
T. Rowe Price Investment Management, Inc. HONE HarborOne Bancorp, Inc. Common Stock 13G 12.5% 2y
Stephen Fredette TOST Toast, Inc. 13G/A 7% 2y
BECK MACK & OLIVER LLC CWGL Crimson Wine Group, Ltd 13G/A 8.7% 2y
GLAZER CAPITAL, LLC PLAO Patria Latin American Opportunity Acquisition Corp. Class A Ordinary Shares 13G/A 5.04% 2y
Westchester Capital Management, LLC CNGL Canna-Global Acquisition Corp. Class A Common Stock 13G/A 1.36% 2y
SOFTBANK GROUP CORP. BABA Alibaba Group Holding Ltd 13G/A 14% 2y
Alexandria Real Estate Equities, Inc. APLT Applied Therapeutics, Inc. Common Stock 13G/A 15.4% 2y
ArrowMark Colorado Holdings LLC CMPR CIMPRESS plc 13G/A 5.13% 2y
ARISTEIA CAPITAL, L.L.C. LBRDK Liberty Broadband Corp 13G/A 8.49% 2y
PRICE T ROWE ASSOCIATES INC /MD/ PEN Penumbra Inc 13G 8% 2y
EVERGREEN CAPITAL MANAGEMENT LLC TEI Templeton Emerging Markets Income Fund 13G/A 6.5% 2y
Point72 Asset Management, L.P. SMTC Semtech Corp 13G/A 2.6% 2y
Rock Springs Capital Management LP SYRE Spyre Therapeutics, Inc. 13G/A 0% 2y
VIKING GLOBAL INVESTORS LP FIVN Five9, Inc. 13G/A 3.7% 2y
Calamos Market Neutral Income Fund, a series of Calamos Investment Trust SGHL Signal Hill Acquisition Corp. Class A Common Stock 13G 0% 2y
Fourthstone LLC PBAM Private Bancorp of America, Inc. 13G/A 9.95% 2y
DRAKE FRED L HBT HBT Financial, Inc. 13G/A 54.7% 2y
COHEN & STEERS, INC. JLL Jones Lang Lasalle Inc 13G/A 0% 2y
RGM Capital, LLC PRO Pros Holdings, Inc. 13G/A 6.06% 2y
Jericho Capital Asset Management L.P. SPHR Sphere Entertainment Co. 13G 8.6% 2y
ARMISTICE CAPITAL, LLC VRAX Virax Biolabs Group Ltd 13G 9.99% 2y
Select Equity Group, L.P. MORN Morningstar, Inc. 13G/A 7% 2y
James K. Sims AIRG Airgain Inc 13G/A 6.5% 2y
Long Focus Capital Management, LLC ADAPY Adaptimmune Therapeutics PLC 13G/A 5.3% 2y
KCK LTD. SGHT Sight Sciences, Inc. 13G/A 9.5% 2y
Divesh Makan BRZE Braze, Inc. 13G/A 15.8% 2y
TURTLE CREEK ASSET MANAGEMENT INC. URBN Urban Outfitters Inc 13G/A 2.5% 2y
T. Rowe Price Investment Management, Inc. ESE Esco Technologies Inc 13G/A 6.6% 2y
Deep Track Capital, LP HRTX Heron Therapeutics, Inc. 13G/A 0% 2y
Pentwater Capital Management LP MANU Manchester United plc 13G 8.1% 2y
Deep Track Capital, LP ETNB 89bio, Inc. Common Stock 13G/A 2.1% 2y
ARMISTICE CAPITAL, LLC SPRB Spruce Biosciences, Inc. 13G 5.48% 2y
Deep Track Capital, LP VALN Valneva SE 13G/A 5.42% 2y
Mark N. Tompkins SERV Serve Robotics Inc. 13G/A 7.4% 2y
Fourthstone LLC TSBK Timberland Bancorp Inc 13G/A 0.83% 2y
T. Rowe Price Investment Management, Inc. BFAM Bright Horizons Family Solutions Inc. 13G 6.5% 2y
Deep Track Capital, LP IMUX Immunic, Inc. 13G/A 0% 2y
William G. Shipley LEGH Legacy Housing Corp 13G/A 11.9% 2y
GREENLIGHT CAPITAL INC COYA Coya Therapeutics, Inc. 13G/A 8.8% 2y
CVI Investments, Inc. XMAX XMax Inc. 13G/A 4.3% 2y
Nantahala Capital Management, LLC NMTC NEUROONE MEDICAL TECHNOLOGIES Corp 13G 5.1% 2y
RGM Capital, LLC VRNT Verint Systems Inc 13G 5.03% 2y
Granahan Investment Management, LLC BMRA Biomerica Inc 13G/A 6.44% 2y
T. Rowe Price Investment Management, Inc. PTC Ptc Inc. 13G 8.1% 2y